Russia's Sputnik V vaccine protects from all known variants of COVID-19: Head of Gamaleya Institute

FPJ Web DeskUpdated: Tuesday, June 22, 2021, 06:17 PM IST
article-image

Amid a rise in several variants of the novel coronavirus, Russia's Sputnik V vaccine can protect against all known variants of the virus. Alexander Gintsburg, head of the Gamaleya Research Institute of Epidemiology and Microbiology, the facility where Sputnik V was developed confirmed this update on Tuesday.

In a statement on Tuesday, Alexander Gintsburg said, "Antibodies developed after vaccination with #SputnikV protect from all variants of COVID known today, starting from the UK variant to the so-called Delta variant, first detected in India."

Sputnik V is the third vaccine after Covishield and Covaxin to have received emergency use approval in India. The two-dose adenoviral vector-based coronavirus vaccine is being administered in selective private hospitals for Rs 1,145 per dose.

Talking about the variants, the UK strain (B.1.1.7), tagged by the World Health Organisation (WHO) as the Alpha variant, was first discovered in Kent in September of last year, while, the Delta (B.1.617.2) variant was first found in India in October of last year. The highly transmissible strain has been identified as one of the drivers of the second wave of Covid-19 infections that devastated parts of the country in May.

On June 17, the Russian Direct Investment Fund (RDIF) on Tuesday said that the Sputnik V COVID-19 vaccine will soon offer a booster shot, adjusted to work against the Delta variant of coronavirus, first detected in India, to other vaccine manufacturers.

Notably, on June 15, RDIF in a study cited that Sputnik V is "more efficient against the Delta variant" of coronavirus than any other vaccine that has published results on the strain so far. The Gamaleya Center study has been "submitted for publication in an international peer-reviewed journal", said a tweet from the Russian-made vaccine's official Twitter handle.

Approved for emergency use in 67 countries, Sputnik V has an efficacy rate of over 91.6 per cent.

(To receive our E-paper on whatsapp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Mumbai updates: Tata Marathon to be held in city on January 15 after two-year gap

Mumbai updates: Tata Marathon to be held in city on January 15 after two-year gap

West Bengal: CBI gets 10-day custody of TMC leader Anubrata Mandal in the cattle smuggling scam

West Bengal: CBI gets 10-day custody of TMC leader Anubrata Mandal in the cattle smuggling scam

Mumbai student wins World Youth Transnational Bridge Championships in Singapore

Mumbai student wins World Youth Transnational Bridge Championships in Singapore

'Please come and stay as long as you want to': Bihar Dy CM Tejashwi Yadav to central agencies

'Please come and stay as long as you want to': Bihar Dy CM Tejashwi Yadav to central agencies

Madras HC quashes FIR against 'Jai Bhim' actor Suriya, director Gnanavelraja for hurting sentiments...

Madras HC quashes FIR against 'Jai Bhim' actor Suriya, director Gnanavelraja for hurting sentiments...